Search
Catalyst Pharmaceuticals Inc
CPRXAdd to Watchlist
31.420USD
0.0000.00%
Close 06/25, 16:00（ET）Quotes delayed by 15 min
3.85BMarket Cap
17.39P/E TTM
Catalyst Pharmaceuticals Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
588.99M
19.78%
EPS(YoY)
1.75
26.68%
Analyst Rating
HOLD
2026-06-25
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Catalyst Pharmaceuticals Inc?
According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 588.99M, with a year-on-year change of 19.78.
What are the current assets of Catalyst Pharmaceuticals Inc?
According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its current assets were 894.03M, with a year-on-year change of 43.36.
What are the total assets of Catalyst Pharmaceuticals Inc?
According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its total assets of Catalyst Pharmaceuticals Inc were 1.10B, with a year-on-year change of 29.66.
What are the total liabilities of Catalyst Pharmaceuticals Inc?
According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Catalyst Pharmaceuticals Inc were 149.71M, with a year-on-year change of 20.95.
What is the total equity of Catalyst Pharmaceuticals Inc?
According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its total equity of Catalyst Pharmaceuticals Inc was 954.27M, with a year-on-year change of 31.15.
What is the net investment of Catalyst Pharmaceuticals Inc?
According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its net investment of Catalyst Pharmaceuticals Inc was -58.00K, with a year-on-year change of 89.57.
What is the net financing of Catalyst Pharmaceuticals Inc?
According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its net financing of Catalyst Pharmaceuticals Inc was -16.99M, with a year-on-year change of -112.08.
What is the Earnings Per Share (EPS) of Catalyst Pharmaceuticals Inc?
According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 1.75, with a year-on-year change of 26.68.
What is the net margin of Catalyst Pharmaceuticals Inc?
According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was 36.39, with a year-on-year change of 9.18.
What is the gross margin of Catalyst Pharmaceuticals Inc?
According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 78.82, with a year-on-year change of 0.54.
What is the Return on Equity (ROE) of Catalyst Pharmaceuticals Inc?
According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was 25.49, with a year-on-year change of -13.26.
What is the Return on Assets (ROA) of Catalyst Pharmaceuticals Inc?
According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was 21.92, with a year-on-year change of -11.62.
What is the operating profit of Catalyst Pharmaceuticals Inc?
According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its operating profit was 257.78M, with a year-on-year change of 32.11.
